Hospital Admission and Management of Febrile Infants < 3 Months

Epidemiology and Risk Assessment

• Infants younger than 3 months have immature immune systems and therefore face a markedly increased risk for invasive bacterial infections such as bacteremia and bacterial meningitis. 1
• Only 58 % of infants with bacteremia or meningitis appear clinically ill, so a well‑appearing infant does not exclude serious bacterial infection (SBI). 1
• The overall risk of SBI in infants aged 29–56 days is ≈ 9 %; neonates < 28 days have an even higher risk of ≈ 13 %. 2
• Infants < 28 days are at higher risk than older infants; a 42‑day‑old infant remains within this vulnerable period. 3

Clinical Presentation

• A heart rate of 128 beats/min and respiratory rate of 32 breaths/min may represent compensatory tachycardia and tachypnea, although these values can still fall within normal limits for this age group. 4
• Normal or “unremarkable” inflammatory markers (e.g., CRP, procalcitonin) do not rule out serious bacterial infection in young infants, because bacterial sepsis can initially present with normal laboratory values. 3

Diagnostic Evaluation (Full Sepsis Work‑up)

• For any febrile infant < 3 months, guidelines recommend a complete sepsis evaluation that includes:
• Hospital admission should occur in a unit staffed by nurses and clinicians experienced in caring for young infants. 5

Management and Treatment

• Empiric parenteral antibiotic therapy must be started after cultures are obtained and continued pending culture results. 5
• Continuous, close monitoring for clinical deterioration is essential because infants can decompensate rapidly. 1
• Even when all outpatient criteria (normal CSF, negative urinalysis, normal inflammatory markers, reliable parental follow‑up within 24 h) are met, hospitalization remains the safer option for this age group due to the high stakes of missed bacterial infection. 5

Viral Considerations

• Viral pathogens such as herpes simplex virus (HSV) and enterovirus can cause severe disease in infants < 3 months and may mimic bacterial sepsis. 1
• The presence of a viral infection does not exclude a concurrent bacterial infection; co‑infection must be considered. 6
• Acyclovir should be considered when HSV infection is suspected, especially in neonates with risk factors. 1
• Antiviral therapy is adjunctive and does not replace empiric antibiotics, which remain the primary treatment for suspected bacterial infection. 3

Factors That May Mask Illness Severity

• Administration of antipyretics within 4 hours of presentation can blunt fever and potentially lead to underestimation of illness severity. 7

Emergency Department Transfer and Management Guidelines for Young Infants

Criteria for Safe Home Management (AAP Guidelines)

• The American Academy of Pediatrics (AAP) states that home management of infants ≤60 days is permissible only when all of the following are confirmed: a normal urinalysis and a normal cerebrospinal fluid (CSF) analysis or a positive enterovirus result. 8

Lack of Diagnostic Confirmation

• In the absence of any performed laboratory testing, none of the AAP‑required safety criteria can be verified, making home management unsafe. 8

Hospitalization Recommendation

• The AAP recommends that, even when outpatient criteria are technically met, hospital admission is the safer option for infants in this age group because of the high risk of missed serious bacterial infection. 8

Return Precautions When Families Decline Transfer

• The AAP advises that families who refuse emergency department transfer should be instructed to return immediately if the infant experiences recurrent vomiting or is unable to feed. 8

• The AAP also specifies that families should seek urgent care if the infant has decreased urine output (fewer than three wet diapers in 24 hours). 8